Hytham Al-Masri
Clinical Pathology/Laboratory Medicine Blue Island, IL
NPI 1841299591 CMS profile 1070309
12935 Gregory St, Metro South Medical Center, Blue Island, IL 60406
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Hytham Al-Masri of Blue Island, IL.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Other Clinical Pathology/Laboratory Medicine in Illinois
Lance Peterson
Clinical Pathology/Laboratory Medicine · Evanston, IL
Renuka Bhaskar
Clinical Pathology/Laboratory Medicine · Bloomington, IL
Anjen Chenn
Clinical Pathology/Laboratory Medicine · Chicago, IL
Yang Xin Fu
Clinical Pathology/Laboratory Medicine · Burr Ridge, IL
Shan Chin Ying
Clinical Pathology/Laboratory Medicine · Chicago, IL
Noman Siddiqui
Clinical Pathology/Laboratory Medicine · Chicago, IL
Related records
Clinical Pathology/Laboratory Medicine in Illinois
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Pathology/Laboratory Medicine
Everyone recorded under this specialty, nationwide.
Doctors in Illinois
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.